Analyst Ratings for Akari Therapeutics (AKTX)
AKTX Rating Summary
AKTX Price Target Summary
- Highest: $5.00 (Maxim Group)
- Lowest: $1.00 (Ladenburg Thalmann)
- Average: $2.53
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$2.53 (+913.3%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
Avg. $ Target:
$2.53 (+913.3%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2026 | Ladenburg Thalmann | Aydi | New Coverage | Buy (N/A) |
1.00 (N/A) |
0.29 (0.25) |
-13.79% | Details |
| 7/18/2025 | Maxim Group | Jason McCarthy | New Coverage | Buy (N/A) |
5.00 (N/A) |
1.13 (0.25) |
-77.88% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
